XHKG
0928
Market cap21mUSD
Dec 05, Last price
0.09HKD
1D
0.00%
Jan 2017
-97.41%
IPO
-99.98%
Name
Life Healthcare Group Ltd
Chart & Performance
P/E
10.41
P/S
0.70
EPS
0.01
Div Yield, %
—
Shrs. gr., 5y
9.01%
Rev. gr., 5y
29.77%
Revenues
234m
+4.39%
Net income
16m
P
CFO
-32m
L-75.97%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Life Healthcare Group Limited, an investment holding company, provides genetic testing and health data analysis services in the People's Republic of China and Hong Kong. The company operates through two segments, Healthcare Products and Services Business, and Money Lending Business. It offers a range of services and solutions for medical and health administration through its non-invasive tumor genetic testing technology. The company also engages in apparel retail; securities trading and investment; and money lending activities. In addition, it provides corporate administrative and healthcare services. The company was formerly known as Tack Fiori International Group Limited and changed its name to Life Healthcare Group Limited in June 2017. Life Healthcare Group Limited was incorporated in 2001 and is based in Wan Chai, Hong Kong.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||